The United States Court of Appeals for the Ninth Circuit issued a ruling June 3 vacating the federal registration for Xtendimax, FeXapan, and Engenia. June 8, an EPA order addressed the sale, distribution, and use of existing stocks of dicamba.
The order first states that the distribution or sale by any person is generally prohibited except for ensuring proper disposal or return to the registrant.
See the video, Tavium: How it differs, tips to consider
The order also states that growers and commercial applicators may use existing stocks that were in their possession on June 3, 2020, the effective date of the court decision. Such use must be consistent with the products' previously approved labels, and may not continue after July 31, 2020.
Peter Dotray, weed scientist with Texas Tech University and Texas A&M AgriLife Extension Service, Lubbock, discusses how producers, who had dicamba in their possession June 3, can maximize its use before the July 31 deadline. He also discusses weed-treatment alternatives. Watch this video to learn more.
Read more about:
DicambaAbout the Author(s)
You May Also Like